111 (YI) Liabilities and Shareholders Equity (2017 - 2025)
111's (YI) quarterly Liabilities and Shareholders Equity came in at $310.2 million in Q4 2025, down 20.07% year-on-year from $388.1 million in Q4 2024, and down 10.56% quarter-over-quarter from $346.8 million in Q3 2025.
111 (YI) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends
111 has disclosed Liabilities and Shareholders Equity across 9 years of filings, most recently posting $310.2 million for Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $310.2 million, down 20.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.0 billion (down 36.83% YoY), and the FY2025 annual result was $306.2 million, down 19.83% from the prior year.
- Liabilities and Shareholders Equity came in at $310.2 million for Q4 2025 at 111, down from $346.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $511.1 million in Q2 2021 to a low of $342381.4 in Q2 2025.
- The 5-year median for Liabilities and Shareholders Equity is $405.0 million (2024), against an average of $335.3 million.
- Across the five-year window, Liabilities and Shareholders Equity jumped 88622.79% in 2022 and plunged 99.91% in 2025, its largest moves.
- 111's Liabilities and Shareholders Equity stood at $492.0 million in 2021, then fell by 0.73% to $488.4 million in 2022, then retreated by 12.16% to $429.0 million in 2023, then fell by 9.54% to $388.1 million in 2024, then declined by 20.07% to $310.2 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $310.2 million (Q4 2025), $346.8 million (Q3 2025), and $342381.4 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 212.04 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 82.32 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 81.65 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 56.69 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 11.30 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.42 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 72.06 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 310.22 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 62.37 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 310.22 Mn |
| Sep 30, 2025 | 346.83 Mn |
| Jun 30, 2025 | 342,381.38 |
| Mar 31, 2025 | 358.76 Mn |
| Dec 31, 2024 | 388.10 Mn |
| Sep 30, 2024 | 431.73 Mn |
| Jun 30, 2024 | 383.81 Mn |
| Mar 31, 2024 | 405.05 Mn |
| Dec 31, 2023 | 429.03 Mn |
| Sep 30, 2023 | 460.66 Mn |
| Jun 30, 2023 | 435,486.50 |
| Mar 31, 2023 | 473,427.19 |
| Dec 31, 2022 | 488.43 Mn |
| Sep 30, 2022 | 429.46 Mn |
| Jun 30, 2022 | 463.40 Mn |
| Dec 31, 2021 | 492.04 Mn |
| Sep 30, 2021 | 484,046.99 |
| Jun 30, 2021 | 511.11 Mn |
| Mar 31, 2021 | 469.99 Mn |
| Dec 31, 2020 | 456.68 Mn |